Dose-escalated intensity-modulated radiotherapy is feasible and may improve locoregional control and laryngeal preservation in laryngo-hypopharyngeal cancers. [electronic resource]
Producer: 20120316Description: 539-47 p. digitalISSN:- 1879-355X
- Adult
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carcinoma, Squamous Cell -- drug therapy
- Cisplatin -- administration & dosage
- Constriction, Pathologic -- etiology
- Deglutition Disorders -- etiology
- Dermatitis -- etiology
- Disease-Free Survival
- Feasibility Studies
- Female
- Fluorouracil -- administration & dosage
- Follow-Up Studies
- Humans
- Hypopharyngeal Neoplasms -- drug therapy
- Induction Chemotherapy -- adverse effects
- Laryngeal Neoplasms -- drug therapy
- Larynx
- Male
- Middle Aged
- Neoplasm Staging
- Organ Sparing Treatments -- methods
- Pharyngeal Diseases -- etiology
- Radiotherapy Dosage
- Radiotherapy, Intensity-Modulated -- adverse effects
- Stomatitis -- etiology
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.